Cargando…
Correction: The histone methyltransferase DOT1L is a new epigenetic regulator of pulmonary fibrosis
Autores principales: | Yang, Di, Xu, Peng, Su, Haibi, Zhong, Wen, Xu, Jie, Su, Zhenghua, Liu, Xinhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8844288/ https://www.ncbi.nlm.nih.gov/pubmed/35165258 http://dx.doi.org/10.1038/s41419-022-04548-8 |
Ejemplares similares
-
The histone methyltransferase DOT1L is a new epigenetic regulator of pulmonary fibrosis
por: Yang, Di, et al.
Publicado: (2022) -
Inhibition of the cardiac fibroblast-enriched histone methyltransferase Dot1L prevents cardiac fibrosis and cardiac dysfunction
por: Xu, Jie, et al.
Publicado: (2022) -
Histone Methyltransferase Dot1L Contributes to RIPK1 Kinase‐Dependent Apoptosis in Cerebral Ischemia/Reperfusion
por: Wang, Jinghuan, et al.
Publicado: (2021) -
Histone methyltransferase Smyd2 contributes to blood‐brain barrier breakdown in stroke
por: Wang, Jinghuan, et al.
Publicado: (2022) -
Histone methyltransferase Smyd2 drives adipogenesis via regulating STAT3 phosphorylation
por: Su, Haibi, et al.
Publicado: (2022)